Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...

Coagulation

Coagulation

The coagulation phase is a critical part of the body's process to prevent blood loss following injury to blood vessels. It involves chemical reactions that form a clot to seal the injured area. The clotting process begins shortly after injury, within 15-20 seconds for severe damage and 1-2 minutes for minor injuries.
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...

Coagulation

Coagulation

Colloidal solids are solid particles suspended in solution. They are usually negatively charged, attracting a compact primary layer of positively charged ions, which attract more counterions to form an electrical double layer. Electrostatic repulsion between the charged double layers prevents the particles from colliding, stabilizing the colloids. These solids are often undesirable because they can contain toxins that are difficult to remove. Coagulation is a technique that helps aggregate and...

Venous Thrombosis III: Interprofessional Care

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...

Extrinsic and Intrinsic Pathways of Hemostasis

Extrinsic and Intrinsic Pathways of Hemostasis

Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which forms a...

Introduction to Hemostasis

Introduction to Hemostasis

Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized, and...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Lactate and Lactate Clearance as Outcome Predictors in Brain-Dead Potential Organs: A Secondary Cohort Analysis Embedded Within a Cluster-Randomized Clinical Trial.

Clinical transplantation·2026

Same author

Prospective, randomized, controlled trial assessing the effects of methylene blue for the prevention of hypotension during renal replacement therapy: protocol paper and statistical analysis plan for the BLUE study.

Critical care science·2026

Same author

Timing of Onset of Persistent Critical Illness in Brazil: A Nested Secondary Analysis of the IMPACTO-MR Cohort Study.

Critical care medicine·2026

Same author

Propofol versus ketamine in rapid sequence intubation in critically ill patients: a prospective, randomized, controlled trial.

Intensive care medicine·2026

Same author

Prospective, randomized, controlled trial comparing PROpofol versus KetaMINE in rapid sequence intubation in critically ill patients (PROMINE): protocol paper and statistical analysis plan.

Critical care science·2025

Same author

Institutional Risk Factors Associated With Healthcare-Associated Infections in Brazilian ICUs: A Nested Cohort Within the IMPACTO-MR Platform.

Critical care medicine·2025

Search research articles

Related Experiment Video

Updated: Jun 12, 2026

Design of Cecal Ligation and Puncture and Intranasal Infection Dual Model of Sepsis-Induced Immunosuppression

Design of Cecal Ligation and Puncture and Intranasal Infection Dual Model of Sepsis-Induced Immunosuppression

Published on: June 15, 2019

Sepsis, coagulation and anticoagulants.

Flavia Ribeiro Machado¹, Murillo Santucci Cesar

¹Department of Anesthesiology, Pain and Critical Care - Federal University of Sao Paulo, Sao Paulo, SP, Brazil.

Endocrine, Metabolic & Immune Disorders Drug Targets

|June 1, 2010

Summary

Sepsis involves severe inflammation and blood clotting issues. This study explores how inflammation drives coagulation and impairs clot removal, discussing therapeutic targets for excessive clotting.

Area of Science:

Pathophysiology
Immunology
Hematology

Background:

Sepsis is a global health crisis with poorly understood mechanisms.
Coagulation abnormalities, including hypercoagulation and reduced fibrinolysis, are key features of sepsis.
The pro-inflammatory state, marked by cytokines and endothelial activation, drives these coagulation alterations.

Purpose of the Study:

To discuss the pathophysiological mechanisms linking inflammation and coagulation in sepsis.
To explore the interplay between inflammatory pathways and the coagulation cascade.
To review therapeutic strategies targeting excessive coagulation in sepsis.

Main Methods:

Literature review of sepsis pathophysiology.
Analysis of molecular mechanisms connecting inflammation and coagulation.

More Related Videos

Cecal Ligation Puncture Procedure

Cecal Ligation Puncture Procedure

Published on: May 7, 2011

Related Experiment Videos

Last Updated: Jun 12, 2026

Design of Cecal Ligation and Puncture and Intranasal Infection Dual Model of Sepsis-Induced Immunosuppression

Design of Cecal Ligation and Puncture and Intranasal Infection Dual Model of Sepsis-Induced Immunosuppression

Published on: June 15, 2019

Cecal Ligation Puncture Procedure

Cecal Ligation Puncture Procedure

Published on: May 7, 2011

Discussion of current and potential therapeutic interventions.

Main Results:

Inflammation significantly exacerbates coagulation and suppresses natural anticoagulant and fibrinolytic mechanisms.
Mutual activation pathways exist between coagulation and inflammation, perpetuating the septic state.
Endothelial activation, platelet release, and microparticle formation are critical components.

Conclusions:

Understanding the intricate link between inflammation and coagulation is crucial for sepsis management.
Therapeutic strategies aimed at controlling excessive coagulation are essential.
Further research into these interconnected pathways may reveal novel treatment options.